Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2025-12-24 @ 4:23 PM
NCT ID:
NCT05805566
Eligibility Criteria:
Inclusion Criteria:
All patients who have joined the Epsilon care pathway since its opening in February 2022, i.e.:
* Patients with post-Covid syndrome referred to the Epsilon sector from the city medicine:
* Patient with documented SARS-Cov2 pneumonia
* With persistent and severe symptoms beyond 4 weeks or complex or disabling symptoms beyond 3 months
* Patient over 18 years old.
Post-hospital sector:
* Patient with documented SARS-Cov2 pneumonia
* Hospitalized for oxygen therapy (at least 48h)
* Not having a referring pulmonologist
* Not institutionalized
* With a life expectancy of more than 6 months.
Exclusion Criteria:
* Patient refusing that this data to be used for research purposes (objection form).
* Patient with untreated comorbidities
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05805566
Study Brief:
Protocol Section:
NCT05805566